Nasdaq · CIK 0001417926
IVF INVO Fertility, Inc.
Insider trading from SEC Form 4. Last filing Dec 5, 2025. Close $0.73 on Oct 9, 2026, 0% from the 52-week low and -99% from the high.
In brief
INVO Fertility, Inc. (IVF) has 7 SEC Form 4 filings on file from 6 insiders, the latest filed on Dec 5, 2025. No insider bought or sold on the open market in the last 90 days; rows filed in that time are grants, exercises, tax withholding and other transactions that carry no view on the price.
1 open-market trade has been scored at IVF. The newest: Matthew K Szot (director) sold $6 of stock on Dec 3, 2025, filed Dec 5, 2025, scored 35 (weak).
Last 90 days
Price and insider trades, last year
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at INVO Fertility, Inc., scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 35Weak | Matthew K Szot director sell | $6 4 shares | -57% | - |
Transactions
Every row filed, 8 in all.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 3, 2025 | Matthew K Szot director | SOpen-market sale Common stock | -4 | $1.52 | $6 | 3 | Dec 5, 2025 |
| Dec 4, 2025 | Matthew K Szot director | JOther Common stock | -3 | $0.00 | $0 | 0 | Dec 5, 2025 |
| Aug 26, 2025 | Steve Shum Chief Executive Officer | AGrant or award Stock Option (right to buy)derivative | +42,000 | $0.00 | $0 | 42,451 | Oct 3, 2025 |
| Aug 26, 2025 | Trent D Davis director | AGrant or award Stock Option (right to buy)derivative | +45,000 | $0.00 | $0 | 45,159 | Aug 28, 2025 |
| Aug 26, 2025 | Andrea Goren Chief Financial Officer | AGrant or award Stock Option (right to buy)derivative | +50,000 | $0.00 | $0 | 50,409 | Aug 28, 2025 |
| Aug 26, 2025 | Rebecca Messina director | AGrant or award Stock Option (right to buy)derivative | +45,000 | $0.00 | $0 | 45,143 | Aug 28, 2025 |
| Aug 26, 2025 | Barbara Ryan director | AGrant or award Stock Option (right to buy)derivative | +45,000 | $0.00 | $0 | 45,157 | Aug 28, 2025 |
| Aug 26, 2025 | Matthew K Szot director | AGrant or award Stock Option (right to buy)derivative | +45,000 | $0.00 | $0 | 45,164 | Aug 28, 2025 |
Insiders
Everyone who has filed a Form 4 here.
- Trent D Davisdirector
- Andrea GorenChief Financial Officer
- Rebecca Messinadirector
- Barbara Ryandirector
- Steve ShumChief Executive Officer
- Matthew K Szotcfo, officer, director
Questions about IVF
Answered from the filings on this page, as of the latest one.
Are insiders buying IVF?
No. In the last 90 days no insider at INVO Fertility, Inc. bought or sold shares on the open market according to SEC Form 4 filings. The rows on file from that period are grants, exercises, tax withholding or other transactions, which carry no view on the price.
Who was the last insider to trade IVF on the open market?
Matthew K Szot (director) sold $6 of IVF on Dec 3, 2025 and filed the Form 4 on Dec 5, 2025. InsiderTell scored 35 (weak).
How many insiders file Form 4 at INVO Fertility, Inc.?
6 people have filed a Form 4 at INVO Fertility, Inc., among them Trent D Davis (director), Andrea Goren (Chief Financial Officer), Rebecca Messina (director). Officers, directors and holders of more than 10% of a share class must report their trades within two business days.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.